PLUSClinical Trials•globenewswire•
Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ™ in Leptomeningeal Metastases
Sentiment:Positive (80)
Summary
REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically relevant outcome measures
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 18, 2025 by globenewswire